Hunan Hansen Pharmaceutical Co.,Ltd.’s Net Profit Rose 13.3% in First Quarter of 2022

Hunan Hansen Pharmaceutical Co.,Ltd. (湖南汉森制药股份有限公司) (002412.SZ) reported a net profit of 51.8 million yuan in the first quarter of 2022, up 13.3% year-on-year.

Meanwhile, the company posted 248.9 million yuan in revenue, up 5.7% year-on-year.

At the end of the reporting period, it had 2.1 billion yuan in total assets and 340.9 million yuan in total liabilities, with a liability-to-asset ratio of 16%.